ClinicalTrials.Veeva

Menu

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Enrolling

Conditions

Chronic Prostatitis
Erectile Dysfunction
Chronic Pelvic Pain Syndrome
Erectile Dysfunction Due to Arterial Disease
Erectile Dysfunction Following Radical Prostatectomy
Erectile Dysfunction Due to Arterial Insufficiency
Erectile Dysfunction Following Radiation Therapy

Treatments

Device: Sham treatment
Device: Radial wave
Device: Focused shockwave

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

Full description

After being informed about the study and potential risks, all patients giving written informed consent will undergo screening to determine eligibility for study entry. Participants who meet eligibility requirements will be randomized in a double blind manner (participant and investigator) to each treatment arm depending on their primary complaint. Participants with erectile dysfunction will be randomized 2:2:1 to either fSWT, rWT or sham therapy. Patients with chronic pelvic pain syndrome will be randomized 1:1 to either fSWT with pelvic floor physical therapy (PFPT) or PFPT with sham treatment.

Enrollment

186 estimated patients

Sex

Male

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following)

  1. Cis-gendered heterosexual adult males18 years old
  2. Stable relationship of more than 3 months duration with currently willing sexual partner and desire for penetration.
  3. Mild to moderate organic erectile dysfunction (IIEF-EF score 11-25) in the last 3 months
  4. If ED responsive or partially responsive to current use of PDE5I, participant must be willing to discontinue PDE5I for 4 weeks prior to trial and remain off PDE5I for the duration of the study. Partially responsive ED is defined as inadequate response for desired sexual activity, or poorly maintained erection despite initially good response.
  5. Agreeable to attempt sexual intercourse at least 4 times per month for duration of study without being under the influence of alcohol or recreational drugs
  6. Morning total testosterone level over 300ng/dL

Exclusion Criteria (ED):

  1. Nerve-injury related ED (/spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting erectile functions (e.g, multiple sclerosis, alzheimer's disease, parkinsons disease, amyotrophic lateral sclerosis)
  2. Untreated hypogonadism (morning total testosterone <300 ng/dL) or on androgen deprivation therapy in the last 12 months
  3. Predominately psychogenic ED based upon expert clinician opinion
  4. Peyronie's disease, palpable plaque or curvature/penile anatomic abnormality that affects penetrative intercourse to any degree
  5. History of non-superficial penile surgery (e.g, penile prosthesis, penectomy, plication, grafting)
  6. History of penile injury or trauma (e.g, priapism, penile fracture)
  7. Use of intracavernosal injection for ED within the last year
  8. If diabetic, HbA1c 8% or higher within the past 12 months
  9. Known corporal veno-occlusive dysfunction based on prior Doppler penile ultrasound
  10. Current tobacco smoker, or has smoked in the past year
  11. Poorly controlled hyperlipidemia
  12. Poorly controlled hypertension
  13. Severe cardiac disease or history of myocardial infarction
  14. History of psychiatric disorder including bipolar disorder, current moderate or severe depression
  15. Patients currently using SSRI or psychotropic medication
  16. Severe ED based on IIEF-EF (score 10 or below)
  17. Current acute prostatitis

Chronic Pelvic Pain Syndrome Group:

Inclusion Criteria (CPPS): (all of the following)

  1. Adult males ≥18 years old
  2. Chronic pelvic pain not explained by concurrent urinary tract infections. urine)
  3. Willing to do PFPT

Exclusion criteria (CPPS):

  1. Nerve-injury related pelvic pain (history of /spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting pain in the pelvic region(Multiple sclerosis, Alzheimer's, Parkinsons disease)
  2. Acute prostatitis or any acute infection of the pelvic region
  3. History of pelvic trauma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

186 participants in 3 patient groups

fSWT
Experimental group
Description:
Focused Shock wave treatments
Treatment:
Device: Focused shockwave
rWT
Active Comparator group
Description:
Radial wave treatments
Treatment:
Device: Radial wave
Sham
Sham Comparator group
Description:
Sham treatments
Treatment:
Device: Sham treatment

Trial contacts and locations

1

Loading...

Central trial contact

Petar Bajic

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems